EDGAR Filing Documents for 0001493152-24-014340

Form 8-K - Current report:

SEC Accession No. 0001493152-24-014340

Filing Date

2024-04-11

Accepted

2024-04-11 17:00:16

Documents

Period of Report

2024-04-05

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm iXBRL	8-K	55539
2		ex10-1.htm	EX-10.1	120945
3		ex10-2.htm	EX-10.2	160533
4		ex10-3.htm	EX-10.3	75943
5		ex10-4.htm	EX-10.4	88077
6		ex10-5.htm	EX-10.5	93190
7		ex99-1.htm	EX-99.1	18103
8		ex99-1_001.jpg	GRAPHIC	12311
9		ex99-1_002.jpg	GRAPHIC	1687
	Complete submission text file	0001493152-24-014340.txt		929057

Data Files

Seq	Description	Document	Type	Size
10	XBRL SCHEMA FILE	nvos-20240405.xsd	EX-101.SCH	3033
11	XBRL LABEL FILE	nvos-20240405_lab.xml	EX-101.LAB	34240
12	XBRL PRESENTATION FILE	nvos-20240405_pre.xml	EX-101.PRE	22371
24	EXTRACTED XBRL INSTANCE DOCUMENT	form8-k_htm.xml	XML	3618

Mailing Address 11120 NE 2ND STREET SUITE 100 BELLEVUE WA 98004

Business Address 11120 NE 2ND STREET SUITE 100 BELLEVUE WA 98004 (206) 617-9797

Novo Integrated Sciences, Inc. (Filer) CIK: 0001138978 (see all company filings)